Jolynn Tumolo

News

Hand Sanitizer, Aloe Gel Under Class I Recall

05/01/2024

Jolynn Tumolo

More than 40 lots of Aruba Aloe Hand Sanitizer Gel and Aruba Aloe Alcoholada Gel are under a Class I recall because they have been found to contain alcohol denatured with methanol.

More than 40 lots of Aruba Aloe...

05/01/2024

Pharmacy Learning Network

News

Genetic Variant Appears to Protect Against Alzheimer Disease in At-Risk Individuals

04/29/2024

Jolynn Tumolo

A genetic variant may decrease the odds of developing Alzheimer disease (AD) by as much as 70% in people who carry the APOE ε4 allele, which is known to significantly increase AD risk. Researchers published the findings online in Acta...

A genetic variant may decrease...

04/29/2024

Neurology

News

Any Level of Leisure-Time Physical Activity Aids in Stroke Prevention

04/25/2024

Jolynn Tumolo

Any amount of leisure-time physical activity helps to lower the risk of stroke compared with inactivity, according to a systematic review and meta-analysis published in the Journal of Neurology, Neurosurgery & Psychiatry.

Any amount of leisure-time...

04/25/2024

Neurology

News

Bill Supports Wage Subsidies, Benefits for Long-Term Care Staff

04/25/2024

Jolynn Tumolo

Rep. Steven Horsford (D, Nevada) recently introduced a bill in the US House of Representatives that aims to improve nursing home care by strengthening wages and benefits for long-term care workers.

Rep. Steven Horsford (D, Nevada)...

04/25/2024

Annals of Long-Term Care

News

Subpotent Antibiotic Pulled

04/24/2024

Jolynn Tumolo

Lupin Pharmaceuticals Inc. is recalling 26,352 bottles of rifampin capsules because the drug is subpotent, according to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report.

Lupin Pharmaceuticals Inc. is...

04/24/2024

Pharmacy Learning Network

News

Skin Med Recalled for Superpotency

04/24/2024

Jolynn Tumolo

Teva Pharmaceuticals USA Inc. is recalling a single lot of isotretinoin capsules over concerns of superpotency. According to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, results from 3-month stability testing...

Teva Pharmaceuticals USA Inc. is...

04/24/2024

Pharmacy Learning Network

News

Bill Promotes Research into Medical Issues of Descendants of Toxic-Exposed Veterans

04/24/2024

Jolynn Tumolo

A bipartisan bill in the US Senate would expand research into birth defects of descendants of veterans exposed to toxic substances, according to Sen. Jon Tester (D, Montana), chairman of the Senate Veterans’ Affairs Committee, who introduced...

A bipartisan bill in the US...

04/24/2024

Veterans Health Today

News

California Man Charged in $10 Million COVID-19 Relief Fraud

04/24/2024

Jolynn Tumolo

A California man allegedly submitted fake tax documents and business records to 3 banks in an attempt to gain more than $10 million in Coronavirus Aid, Relief, and Economic Security Act loans, according to the US Department of Justice’s...

A California man allegedly...

04/24/2024

Integrated Healthcare Executive

News

Prasinezumab May Benefit Early-Stage Parkinson Patients With Rapid Progression

04/23/2024

Jolynn Tumolo

Prasinezumab may ease motor worsening to a greater extent in patients with more rapidly progressing early-stage Parkinson disease (PD) than in other early-stage PD patients, according to an exploratory analysis.

Prasinezumab may ease motor...

04/23/2024

Neurology

News

Antipsychotics for Dementia Associated With More Adverse Outcomes Than Previously Thought

04/22/2024

Jolynn Tumolo

Antipsychotic use in patients with dementia is associated with an increased risk for a handful of serious adverse outcomes, including pneumonia, acute kidney injury, venous thromboembolism, and stroke.

Antipsychotic use in patients...

04/22/2024

Psych Congress Network